Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-06-000509
Filing Date
2006-02-08
Accepted
2006-02-08 16:40:03
Documents
1
Period of Report
2006-02-06

Document Format Files

Seq Description Document Type Size
1 p642039_ex.html 4  
1 p642039_ex.xml 4 9156
  Complete submission text file 0000919574-06-000509.txt   10961
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 212-551-1600
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50577 | Film No.: 06589527